Isaeva, A,
Averyanov, S,
Iskhakov, I,
Galimov, S,
Galimova, E,
Kiniabaev, T (2021) Biomarkers of inflammation can be used as indicators for monitoring the treatment of periodontal
Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) of clinical trials dedicated to oncourology have begun, using lncRNA as new
biomarkers or treatments
Gareev, Ilgiz,
Beylerli, Ozal,
Yang, Guang,
Izmailov, Adel,
Shi, Huaizhang,
Sun, Jinxian,
Zhao, Boxian,
Liu, Binbing,
Zhao, Shiguang (2021) RNAs are considered as new potential
biomarkers of interest in many diseases, including IA.
Sun, J.X.,
Sun, Z.Y.,
Gareev, I,
Yan, T,
Chen, X,
Ahmad, A,
Zhang, D.M.,
Zhao, B.X.,
Beylerli, O.,
Yang, G.,
Zhao, S.G. (2021) communication and are potential diagnostic and prognostic
biomarkers for various cancers. This study focused
Beylerli, O.,
Khasanov, D.,
Gareev, I.,
Valitov, E.,
Sokhatskii, A.,
Wang, C.,
Pavlov, V.,
Khasanova, G.,
Ahmad, A. (2021) elevated in the PAs. Therefore, miR-200a and lncRNA ANRIL represents as
biomarkers for diagnosis